000 01615cam  2200373zi 4500
0019.886144
003CaOODSP
00520221107171333
006m     o  d f      
007cr |||||||||||
008200422t20202020onc     ob   f00| 0 eng d
020 |a9780660347059
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH139-15/2020E-PDF
24500|aGood manufacturing practices guide for drug products.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2020.
264 4|c©2020
300 |a1 online resource (159 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Lignes directrices sur les bonnes pratiques de fabrication des drogues.
500 |aIssued also in HTML format.
500 |a"GUI-0001."
500 |a"July 1, 2020."
500 |a"Replaces: Good manufacturing practices guide for drug products (GUI-0001) (February 28, 2018)."
504 |aIncludes bibliographical references (pages 152-159).
650 0|aDrug factories|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tLignes directrices sur les bonnes pratiques de fabrication des drogues.|w(CaOODSP)9.886147
85640|qPDF|s2.36 MB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H139-15-2020-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gmp-guidelines-0001/document.html